 AUSTIN, Texas, Aug. 05, 2020 GLOBE NEWSWIRE -- Ideal Power Inc. Nasdaq: IPWR the Company or Ideal Power has completed an early warrant exercise transaction with certain of the Companys Series A warrant holders through a letter of agreement between the Company and such Series A warrant holders. The transaction raised approximately 2.7 million in gross proceeds. Ideal Power intends to use the proceeds from the transaction to fund commercialization and development of the Companys patented Bi-directional, Bi-polar Junction Transistor B-TRANTM semiconductor technology and general corporate and working capital purposes.This transaction strengthens our cash position, enables an orderly exercise of warrants for holders, and provides additional resources for us to execute our Phase Two commercial plan while avoiding the need to access the capital markets in the current volatile environment, said Dan Brdar, President and Chief Executive Officer of Ideal Power. Having built a solid strategic foundation, we are working diligently toward commercialization of our innovative B-TRANTM bi-directional power switch technology. We thank our Series A warrant holders for their continued support.Management will discuss its strategic progress further when it reports second quarter 2020 results on August 13, 2020.As an incentive for the Series A warrant holders to exercise their Series A warrants early, the Series A warrant holders were issued new Series C warrants to purchase up to an aggregate of 705,688 shares of the Companys common stock, at an exercise price of 8.90 per share, through a private placement.Craig-Hallum Capital Group acted as the exclusive placement agent for this transaction.The Series C warrants and shares of common stock underlying the Series C warrants issued in this transaction have not been registered under the Securities Act of 1933, as amended the Securities Act, or state securities laws and may not be offered or sold in the United States absent registration with the Securities and Exchange Commission the SEC or an applicable exemption from such registration requirements. Ideal Power has agreed to file a registration statement with the SEC covering the resale of the shares of common stock underlying the Series C warrants. This press release does not constitute an offer to sell, or the solicitation of an offer to buy, securities of the Company in the United States.About Ideal Power Inc.Ideal Power Nasdaq: IPWR is pioneering the development of its broadly patented bi-directional power switches, creating highly efficient and ecofriendly energy control solutions for industrial, alternative energy, military and automotive applications. The Company is focused on its patented Bi-directional, Bi-polar Junction Transistor B-TRANTM semiconductor technology. B-TRANTM is a unique double-sided bi-directional AC switch able to deliver substantial performance improvements over todays conventional power semiconductors. Ideal Power believes B-TRANTM modules will reduce conduction and switching losses, complexity of thermal management and operating cost in medium voltage AC power switching and control circuitry. For more information, visit StatementsAll statements in this release that are not based on historical fact are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and the provisions of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended. While Ideal Powers management has based any forward-looking statements included in this release on its current expectations, the information on which such expectations were based may change. These forward-looking statements rely on a number of assumptions concerning future events and are subject to a number of risks, uncertainties and other factors, many of which are outside of our control that could cause actual results to materially differ from such statements. Such risks, uncertainties, and other factors include, but are not limited to, the impact of COVID-19 on our business, financial condition and results of operations, the success of our B-TRANTM technology, including the success of our government-funded technology demonstration project, whether the patents for our technology provide adequate protection and whether we can be successful in maintaining, enforcing and defending our patents and our inability to predict with precision or certainty the pace of development and commercialization of our B-TRANTM technology, our ability to secure additional financing on commercially reasonable terms or at all, especially in light of the market volatility and uncertainty as a result of the COVID-19 outbreak, and uncertainties set forth in our quarterly, annual and other reports filed with the SEC. Furthermore, we operate in a highly competitive and rapidly changing environment where new and unanticipated risks may arise. Accordingly, investors should not place any reliance on forward-looking statements as a prediction of actual results. We disclaim any intention to, and undertake no obligation to, update or revise forward-looking statements.Ideal Power Investor Relations Contact: LHA Investor Relations Carolyn Capaccio, CFA Keith Fetter T: 212-838-3777 